Characteristics of Patients in the 10th and 90th Percentile of LDL-C Reductions with Alirocumab: ODYSSEY Pooled AnalysesRobert S. Rosenson,Eli M. Roth,Kausik K. Ray,G. Kees Hovingh,Harold E. Bays,Ulrich Laufs,Daniel J. Rader,Marie T. Baccara-Dinet,Desmond Thompson,Michael J. Louie,Lawrence A. LeiterAtherosclerosis Supplements(2018)引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要